Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2804910rdf:typepubmed:Citationlld:pubmed
pubmed-article:2804910lifeskim:mentionsumls-concept:C1512162lld:lifeskim
pubmed-article:2804910lifeskim:mentionsumls-concept:C1519429lld:lifeskim
pubmed-article:2804910lifeskim:mentionsumls-concept:C0596382lld:lifeskim
pubmed-article:2804910lifeskim:mentionsumls-concept:C0026986lld:lifeskim
pubmed-article:2804910pubmed:issue11lld:pubmed
pubmed-article:2804910pubmed:dateCreated1989-12-15lld:pubmed
pubmed-article:2804910pubmed:abstractTextNumerous morphologic features have been described in bone marrow and peripheral blood in myelodysplastic syndrome (MDS). We draw attention to a high incidence of a subtle morphologic feature, internuclear bridging (INB), not previously recognized as a morphologic feature in MDS. The occurrence of INB in MDS suggests an underlying abnormality of mitotic division that could explain the impaired production of hematopoietic cells, the addition and deletion cytogenetic changes, and the stepwise disease progression and cytogenetic progression characteristic of MDS. Lack of awareness that INB occurs in MDS may cause confusion of MDS and congenital dyserythropoietic anemia type I, a congenital process also characterized by INB.lld:pubmed
pubmed-article:2804910pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2804910pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2804910pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2804910pubmed:languageenglld:pubmed
pubmed-article:2804910pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2804910pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2804910pubmed:statusMEDLINElld:pubmed
pubmed-article:2804910pubmed:monthDeclld:pubmed
pubmed-article:2804910pubmed:issn0008-543Xlld:pubmed
pubmed-article:2804910pubmed:authorpubmed-author:BennettJ MJMlld:pubmed
pubmed-article:2804910pubmed:authorpubmed-author:MorrisonF SFSlld:pubmed
pubmed-article:2804910pubmed:authorpubmed-author:HeadD RDRlld:pubmed
pubmed-article:2804910pubmed:authorpubmed-author:MillerK BKBlld:pubmed
pubmed-article:2804910pubmed:authorpubmed-author:GreverM RMRlld:pubmed
pubmed-article:2804910pubmed:authorpubmed-author:KopeckyKKlld:pubmed
pubmed-article:2804910pubmed:authorpubmed-author:GrenierKKlld:pubmed
pubmed-article:2804910pubmed:issnTypePrintlld:pubmed
pubmed-article:2804910pubmed:day1lld:pubmed
pubmed-article:2804910pubmed:volume64lld:pubmed
pubmed-article:2804910pubmed:ownerNLMlld:pubmed
pubmed-article:2804910pubmed:authorsCompleteYlld:pubmed
pubmed-article:2804910pubmed:pagination2199-2202lld:pubmed
pubmed-article:2804910pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2804910pubmed:meshHeadingpubmed-meshheading:2804910-...lld:pubmed
pubmed-article:2804910pubmed:meshHeadingpubmed-meshheading:2804910-...lld:pubmed
pubmed-article:2804910pubmed:meshHeadingpubmed-meshheading:2804910-...lld:pubmed
pubmed-article:2804910pubmed:meshHeadingpubmed-meshheading:2804910-...lld:pubmed
pubmed-article:2804910pubmed:meshHeadingpubmed-meshheading:2804910-...lld:pubmed
pubmed-article:2804910pubmed:meshHeadingpubmed-meshheading:2804910-...lld:pubmed
pubmed-article:2804910pubmed:year1989lld:pubmed
pubmed-article:2804910pubmed:articleTitlePathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative Study.lld:pubmed
pubmed-article:2804910pubmed:affiliationSt. Jude Children's Research Hospital, Memphis, Tennessee.lld:pubmed
pubmed-article:2804910pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2804910pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed